Health

University of Manchester receives $1.3 million international donation to create new cancer research fund

20 November 2024 The University of Manchester has received a $1.3 million donation from alumna Judith Sear to accelerate the University’s cancer research impact. The generous gift, which was made to the North American Foundation for The University of Manchester (NAFUM), will create the Sear Family Cancer Research Fund – a dedicated fund within the […]

University of Manchester receives $1.3 million international donation to create new cancer research fund Read More »

Manchester scientists develop ai trial to help people survive cancer

4 November 2024 Manchester scientists and clinicians have been awarded a major cash boost to fund pioneering radiotherapy research which uses artificial intelligence to help save lives. Cancer Research UK is investing a total of £5.9 million to develop new radiotherapy technologies and techniques over the next five years. In close collaboration with The Christie, the

Manchester scientists develop ai trial to help people survive cancer Read More »

The University of Manchester and Vernacare join forces to revolutionise plastic use in healthcare

29 October 2024 The University of Manchester is teaming up with Vernacare to revolutionise the use of single-use plastics in healthcare.  Plastics play a crucial role in healthcare, but the current linear model of using and then incinerating leads to significant waste and environmental harm. Through a Knowledge Transfer Partnership (KTP), materials experts at Manchester

The University of Manchester and Vernacare join forces to revolutionise plastic use in healthcare Read More »

NanoNeuroOmics – Using nanotechnology to tackle brain diseases

9 October 2024 Alzheimer’s disease and glioblastoma are two of the most devastating and challenging brain disorders we can face. There’s not currently a cure for either. Yet they also have a surprising connection. Emerging epidemiological studies suggest that people who have one of these conditions, seem to experience a reduction in the chance of

NanoNeuroOmics – Using nanotechnology to tackle brain diseases Read More »

Machine learning powers discovery of new molecules to enhance the safe freezing of medicines and vaccines

16 September 2024 Scientists from The University of Manchester and the University of Warwick have developed a cutting-edge computational framework that enhances the safe freezing of medicines and vaccines. Treatments such as vaccines, fertility materials, blood donations, and cancer therapies often require rapid freezing to maintain their effectiveness. The molecules used in this process, known

Machine learning powers discovery of new molecules to enhance the safe freezing of medicines and vaccines Read More »

Scientists develop artificial sugars to enhance disease diagnosis and treatment accuracy

13 September 2024 Scientists have found a way to create artificial sugars that could lead to better ways to diagnose and treat diseases more accurately than ever before. Sugars play a crucial role in human health and disease, far beyond being just an energy source. Complex sugars called glycans coat all our cells and are

Scientists develop artificial sugars to enhance disease diagnosis and treatment accuracy Read More »

Manchester researcher awarded €1.5m ERC grant to revolutionise early detection of brain diseases

9 September 2024 A leading nanomedicine researcher at The University of Manchester has secured a €1.5m (£1.3m) European Research Council (ERC) Starting Grant to push forward pioneering research on Alzheimer’s disease and glioblastoma. The five-year project, NanoNeuroOmics, aims to combine breakthroughs in nanotechnology, protein analysis, and blood biomarker discovery to make advances in two key

Manchester researcher awarded €1.5m ERC grant to revolutionise early detection of brain diseases Read More »

New method could lower radiotherapy doses for some cancer patients

15 August 2024 A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients. The study led by scientists at The University of Manchester and The Institute of Cancer Research, London, could potentially benefit patients by using a technique called Oxygen-enhanced magnetic resonance imaging (OE-MRI).

New method could lower radiotherapy doses for some cancer patients Read More »

Ground-breaking study reveals previously unknown genetic causes of colorectal cancer

8 August 2024 A pioneering study, led by UK universities*, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC). Cancers develop partly through genetic abnormalities within cells of

Ground-breaking study reveals previously unknown genetic causes of colorectal cancer Read More »

Women at lower risk of breast cancer after ovarian cancer diagnosis, research shows

25 July 2024 Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from Manchester University NHS Foundation Trust (MFT)  and The University of Manchester has revealed. MFT researchers say it is likely this is because of the platinum-based chemotherapy that

Women at lower risk of breast cancer after ovarian cancer diagnosis, research shows Read More »

Scroll to Top